{"symbol":"SYK","fiscalQuarter":"Q1-2026","reportDate":"2026-04-30","reportTime":"AMC","status":"reported","company":{"name":"Stryker Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/SYK/earnings/Q1-2026","estimates":{"consensusEps":2.9838,"consensusRevenue":6329.45,"epsLow":2.86,"epsHigh":3.07,"whisperEps":null,"numAnalysts":null},"preBrief":{"companySnapshot":"Stryker Corporation (SYK) is a leading medical technology company that develops and manufactures innovative healthcare equipment. Operating in the health care sector, Stryker focuses on products that enhance surgical outcomes and improve patient care, making it a significant player in the medical device industry.","keyMetrics":[{"name":"EPS","why":"Earnings per share is a key indicator of profitability and will show how well Stryker is managing costs and generating income.","consensus":"$2.98"},{"name":"Revenue","why":"Total revenue reflects the company's sales performance and market demand for its products, which is crucial for assessing growth.","consensus":"$6.3B"}],"lastQuarterRecap":{"summary":"In Q4-2025, Stryker reported an EPS of $4.47, beating estimates by 1.71%. However, the stock experienced a slight decline of 0.99% the following day.","promises":[]},"wallStreetExpectations":{"summary":"Analysts expect Stryker to continue its trend of exceeding earnings expectations, with a consensus EPS of $2.98 and revenue of $6.3B. The market is closely watching for any signs of growth in demand for its products.","bullCase":"If Stryker beats earnings expectations again, it could indicate strong operational efficiency and demand, potentially driving the stock higher as investors gain confidence in its growth trajectory.","bearCase":"Conversely, if Stryker fails to meet expectations, it may raise concerns about market demand and profitability, leading to a negative reaction from investors."},"optionsSignal":{"impliedMove":"6.51%","context":"The options market is pricing in a significant move around the earnings report, suggesting that traders expect volatility based on the upcoming results."},"earningsTrackRecord":[{"quarter":"Q4-2025","epsSurprise":"+1.71%","reaction":"-0.99%"},{"quarter":"Q3-2025","epsSurprise":"+1.66%","reaction":"-0.17%"},{"quarter":"Q2-2025","epsSurprise":"+2.05%","reaction":"-1.92%"},{"quarter":"Q1-2025","epsSurprise":"+4.18%","reaction":"+0.02%"},{"quarter":"Q4-2024","epsSurprise":"+3.51%","reaction":"-1.19%"}],"pivotalQuestions":[{"question":"Will Stryker's EPS exceed the consensus estimate of $2.98?","whyItMatters":"A beat on EPS would reinforce Stryker's strong operational performance and could boost investor confidence."},{"question":"What are the revenue growth prospects for Stryker's key product lines?","whyItMatters":"Understanding revenue growth will provide insight into market demand and the company's competitive position in the healthcare equipment sector."}],"thesisBreakLevels":{"bullTrigger":"An EPS of $3.05 or higher would confirm the bull case, indicating strong demand and cost management.","bearTrigger":"An EPS below $2.86 would confirm the bear case, suggesting potential issues with profitability or market demand.","context":"This quarter, the focus is on Stryker's ability to maintain its growth trajectory amid competitive pressures and market dynamics."},"scenarioPlaybook":{"beatAndRaise":"If Stryker beats expectations, history suggests the stock could rise by about 0.84%, confirming strong operational performance.","inLineCautious":"An inline result may lead to a muted reaction, as investors await further guidance on future growth.","miss":"If Stryker misses expectations, the stock could decline, with historical patterns suggesting a potential drop of around 0.63%."},"whatTheStreetIsMissing":{"thesis":"The Street may underestimate Stryker's ability to leverage its innovative product pipeline, which could lead to stronger-than-expected revenue growth this quarter.","supportingPoints":["Stryker has consistently beaten EPS estimates in the past, indicating strong operational execution.","The options market is pricing in a larger move than historical averages, suggesting that traders expect significant news.","Recent insider trading activity shows mixed signals, which may indicate uncertainty about future performance."],"riskToConsensus":"If Stryker's revenue growth exceeds $6.5B, it could challenge the current cautious consensus."},"whatToListenFor":["Any updates on new product launches and their expected impact on revenue.","Management's commentary on market demand and competitive landscape.","Insights into cost management strategies and their effect on margins.","Guidance on future revenue growth and any changes to long-term targets.","Responses to questions regarding supply chain challenges and their impact on operations."],"metaDescription":"Stryker (SYK) reports Q1 2026 earnings April 30. Analysts expect $2.98 EPS on $6.3B revenue. Here's what to watch."},"postBrief":{"headline":"Stryker Corporation Misses on EPS, Stock Up 0.00%","keyNumbers":[{"metric":"EPS","actual":"$2.60","expected":"$2.98","surprise":"-12.63%"},{"metric":"Revenue","actual":"N/A","expected":"$6.3B","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record for this earnings call, so the analysis is based solely on the numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"Stryker Corporation reported earnings that fell short of analyst expectations, particularly in EPS. Despite the miss, the stock showed no movement, remaining stable. Investors may be awaiting further insights from future earnings calls or additional guidance.","metaDescription":"Stryker Corporation (SYK) Q1 2026 earnings: EPS missed by 12.63%. Stock unchanged at 0.00%. Full breakdown."}}